The Claim
In bovine hepatocytes, exposure to sodium acetate at concentrations of 3.6–7.2 mM is associated with reduced expression and transcriptional activity of SREBP-1c and ChREBP, resulting in decreased mRNA levels of the lipogenic genes ACC1, FAS, and SCD-1, which suggests suppression of de novo lipogenesis.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
When cow liver cells are exposed to certain levels of sodium acetate, it seems to turn down the activity of genes involved in making fat, which might mean the cells make less fat.
See the scientific wording
In bovine hepatocytes, exposure to 3.6–7.2 mM sodium acetate is associated with reduced expression and transcriptional activity of SREBP-1c and ChREBP, leading to decreased mRNA levels of lipogenic genes ACC1, FAS, and SCD-1, suggesting suppression of de novo lipogenesis.
What the research says
1 studyThe study tested sodium acetate in cow liver cells and found it turned down the activity of key genes that make fat, which matches what the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.